Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations (Q36359653)

13 August 2017

1 reference

title

Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations (English)

1 reference

13 August 2017

16

Ruth Kleinerman

1 reference

13 August 2017

23

Nathaniel Rothman

1 reference

13 August 2017

20

Kenneth Offit

1 reference

13 August 2017

9

Stephen Chanock

1 reference

13 August 2017

21

Ching-Hon Pui

1 reference

13 August 2017

6

Christine B Ambrosone

1 reference

13 August 2017

1

Lois B Travis

1 reference

13 August 2017

22

Leslie L Robison

1 reference

13 August 2017

Charles S Rabkin

2

1 reference

13 August 2017

Linda Morris Brown

3

1 reference

13 August 2017

James M Allan

4

1 reference

13 August 2017

Blanche P Alter

5

1 reference

13 August 2017

Colin B Begg

7

1 reference

13 August 2017

Neil Caporaso

8

1 reference

13 August 2017

Angela DeMichele

10

1 reference

13 August 2017

William Douglas Figg

11

1 reference

13 August 2017

Mary K Gospodarowicz

12

1 reference

13 August 2017

Eric J Hall

13

1 reference

13 August 2017

Michie Hisada

14

1 reference

13 August 2017

Peter Inskip

15

1 reference

13 August 2017

John B Little

17

1 reference

13 August 2017

David Malkin

18

1 reference

13 August 2017

Andrea K Ng

19

1 reference

13 August 2017

Peter G Shields

24

1 reference

13 August 2017

Louise Strong

25

1 reference

13 August 2017

Toshiyasu Taniguchi

26

1 reference

13 August 2017

Margaret A Tucker

27

1 reference

13 August 2017

Mark H Greene

28

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

Journal of the National Cancer Institute

13 August 2017

published in

1 reference

13 August 2017

volume

98

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

15-25

1 reference

Gene expression profiling predicts clinical outcome of breast cancer

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Individualized care for patients with cancer - a work in progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Therapy-associated solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Lung cancer after treatment for Hodgkin's disease: focus on radiation effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Hereditary cancer predisposition syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

The concise handbook of family cancer syndromes. Mayo Familial Cancer Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Prevention and management of hereditary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Cancer in Fanconi anemia, 1927-2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Multiple primary cancers in families with Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Early onset brain tumor and lymphoma in MSH2-deficient children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Cancer risks in BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Cancer Incidence in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

BRCA mutations and risk of prostate cancer in Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

BRCA1 and BRCA2 germline mutations in lymphoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation-Negative Hereditary Breast Cancer Families

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

CHEK2 is a multiorgan cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Cancer incidence in persons with Fanconi anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

The Fanconi anaemia/BRCA pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Hallmarks of 'BRCAness' in sporadic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Genome-wide discovery of loci influencing chemotherapy cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Pharmacogenomics--drug disposition, drug targets, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Pharmacogenomics of ABC transporters and its role in cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Second cancers in survivors of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Moving towards individualized medicine with pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

High incidence of secondary brain tumours after radiotherapy and antimetabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Clinical pharmacokinetics-pharmacodynamics of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

XRCC1 and glutathione-S-transferase gene polymorphisms and susceptibility to radiotherapy-related malignancies in survivors of Hodgkin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Dietary factors and second primary cancers: A follow‐up of oral and pharyngeal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

The genetic defect in ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Cancer risks and mortality in heterozygous ATM mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Radiation-induced genomic instability: delayed mutagenic and cytogenetic effects of X rays and alpha particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Second cancers after radiotherapy: any evidence for radiation-induced genomic instability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

High-resolution haplotype structure in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Molecular characteristics of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Molecular profiling of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Atm heterozygous mice are more sensitive to radiation-induced cataracts than are their wild-type counterparts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Molecular cloning and analysis of Schizosaccharomyces pombe rad9, a gene involved in DNA repair and mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

A human homolog of the Schizosaccharomyces pombe rad9+ checkpoint control gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Deletion of mouse rad9 causes abnormal cellular responses to DNA damage, genomic instability, and embryonic lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Use of OctoChrome fluorescence in situ hybridization to detect specific aneuploidy among all 24 chromosomes in benzene-exposed workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Alcohol as a co-factor in the etiology of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Radiation-induced second cancers: the impact of 3D-CRT and IMRT

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

131I-tositumomab therapy as initial treatment for follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

What are the information priorities for cancer patients involved in treatment decisions? An experienced surrogate study in Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

High throughput screening of genetic polymorphisms by matrix-assisted laser desorption ionization time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Integrating ethics and science in the International HapMap Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Comparison of yield and genotyping performance of multiple displacement amplification and OmniPlex whole genome amplified DNA generated from multiple DNA sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

Frequency of BRCA1 and BRCA2 Mutations in Unselected Ashkenazi Jewish Patients With Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ001

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJJ001

1 reference

13 August 2017

1 reference